Visualization of Lung Inflammation to Pulmonary Fibrosis via Peroxynitrite Fluctuation

Zixuan Zhan, Rui Liu, Li Chai1

  • 1Core Facility of West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , China.

Analytical Chemistry
|August 1, 2019
PubMed

Insights

Researchers developed a novel fluorescent probe, rTPONOO-1, to detect peroxynitrite in lung tissues. This tool aids in early idiopathic pulmonary fibrosis (IPF) diagnosis and assessing treatment effectiveness.

Area of Science:

  • Biomedical Engineering
  • Medical Diagnostics
  • Pulmonary Medicine

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a severe lung disease with poor prognosis.
  • Early diagnosis of IPF is challenging due to unknown causes and lack of noninvasive methods.
  • Mitochondrial oxidative stress is implicated in the progression of pulmonary fibrosis.

Purpose of the Study:

  • To develop a novel fluorescent probe for simultaneous detection in the near-infrared (NIR)-Ia window.
  • To investigate the role of peroxynitrite (ONOO-) in various lung conditions, from healthy to fibrotic states.
  • To evaluate the therapeutic efficacy of aminoguanidine hemisulfate salt (AG) in pulmonary fibrosis.

Main Methods:

  • A ratiometric fluorescent probe, rTPONOO-1, with two-photon and mitochondria-targeting capabilities was synthesized.
  • The probe was used to monitor ONOO- levels in lung slices representing different stages of fibrosis.
  • Correlation between probe fluorescence and fibrosis severity (assessed by H&E and Masson staining) was analyzed.

Main Results:

  • The ratiometric fluorescence changes of rTPONOO-1 showed a linear correlation with the progression rate of pulmonary fibrosis.
  • The probe successfully visualized ONOO- levels in different lung states.
  • The study demonstrated the potential of AG as a therapeutic agent.

Conclusions:

  • The ratiometric fluorescent probe rTPONOO-1 is a promising tool for early IPF diagnosis and progression monitoring.
  • rTPONOO-1 facilitates the study of peroxynitrite's role in lung fibrosis.
  • The findings support the potential of rTPONOO-1 in guiding effective IPF treatment strategies.

Related Concept Videos

Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.1K
Inflammation01:38

Inflammation

Overview
61.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
738
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
484
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
869
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K